As of 3:59pm ET
| +1.30 / +1.57%|
The 11 analysts offering 12-month price forecasts for Integra LifeSciences Holdings Corp have a median target of 81.00, with a high estimate of 90.00 and a low estimate of 75.00. The median estimate represents a -3.88% decrease from the last price of 84.27.
The current consensus among 15 polled investment analysts is to Buy stock in Integra LifeSciences Holdings Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.